Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1984 1
1995 1
1996 1
1997 1
1998 1
1999 2
2000 1
2002 3
2012 1
2015 1
2017 3
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

17 results
Results by year
Filters applied: . Clear all
Page 1
Oral ganciclovir for cytomegalovirus infections.
Follansbee SE, Stempien MJ, Buhles WC. Follansbee SE, et al. Among authors: stempien mj. Adv Exp Med Biol. 1996;394:93-103. doi: 10.1007/978-1-4757-9209-6_11. Adv Exp Med Biol. 1996. PMID: 8815713 Review. No abstract available.
High dose oral ganciclovir treatment for cytomegalovirus retinitis.
Lalezari JP, Friedberg DN, Bissett J, Giordano MF, Hardy WD, Drew WL, Hubbard LD, Buhles WC, Stempien MJ, Georgiou P, Jung DT, Robinson CA; Roche Cooperative Oral Ganciclovir Study Group. Lalezari JP, et al. Among authors: stempien mj. J Clin Virol. 2002 Feb;24(1-2):67-77. doi: 10.1016/s1386-6532(01)00229-3. J Clin Virol. 2002. PMID: 11744430 Clinical Trial.
A safety study of oral valganciclovir maintenance treatment of cytomegalovirus retinitis.
Lalezari J, Lindley J, Walmsley S, Kuppermann B, Fisher M, Friedberg D, Lalonde R, Matheron S, Nieto L, Torriani FJ, Van Syoc R, Sutton MA, Buhles W, Stempien MJ; Roche Valganciclovir Study Group. Lalezari J, et al. Among authors: stempien mj. J Acquir Immune Defic Syndr. 2002 Aug 1;30(4):392-400. doi: 10.1097/00042560-200208010-00004. J Acquir Immune Defic Syndr. 2002. PMID: 12138345 Clinical Trial.
Randomized, placebo-controlled trial of ADS-5102 (amantadine) extended-release capsules for levodopa-induced dyskinesia in Parkinson's disease (EASE LID 3).
Oertel W, Eggert K, Pahwa R, Tanner CM, Hauser RA, Trenkwalder C, Ehret R, Azulay JP, Isaacson S, Felt L, Stempien MJ. Oertel W, et al. Among authors: stempien mj. Mov Disord. 2017 Dec;32(12):1701-1709. doi: 10.1002/mds.27131. Epub 2017 Aug 21. Mov Disord. 2017. PMID: 28833562 Free PMC article. Clinical Trial.
17 results